Trends - hydroxychloroquine - Business Recorder

hydroxychloroquine

WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients

These therapies - artesunate, imatinib and infliximab - were selected by an independent expert panel for their potential in reducing the risk of death in hospitalised COVID-19 patients

Updated 11 Aug, 2021 06:29pm

Technology

Sky News Australia says suspended from YouTube for one week

YouTube, owned by Alphabet Inc's Google, confirmed the suspension

Published 01 Aug, 2021 01:16pm

World

Aspirin does not improve survival in COVID-19 patients: UK study

The scientists behind the trial, which is looking into a range of potential treatments for COVID-19, evaluated aspirin's effects on nearly 15,000 hospitalised patients infected with the novel coronavirus.
In the study, named RECOVERY, a little less than half of the patients were selected at random and given 150mg of aspirin once a day, and the remaining were given usual care alone.

Published 08 Jun, 2021 05:40pm

World

Brazil surpasses 300,000 Covid-19 deaths

Bolsonaro has softened his position on vaccines under pressure, saying Wednesday's meeting had "unanimously agreed" on the need for mass vaccination.

Published 25 Mar, 2021 10:57am

World

Australian MP who promoted pandemic conspiracies quits ruling party

Kelly's Facebook account -- which also frequently plays down climate change -- had around six million video views and five million interactions in 2020, according to data tool CrowdTangle.

Published 23 Feb, 2021 09:52am

World

Fauci says he feels liberated to speak on science under Biden

"The idea that you can get up here and talk about what you know. What the evidence, what the science is, and know that's it -- let the science speak -- it is somewhat of a liberating feeling."

Published 22 Jan, 2021 10:00am

World

Covid-19: Twelve key milestones

On December 31, 2019, the World Health Organization (WHO) is alerted to a cluster of pneumonia cases "of unknown cause" in the central Chinese city of Wuhan.

Published 10 Jan, 2021 11:27am

World

Global COVID-19 prevention trial of hydroxychloroquine to resume

Global trial is part of search for way to prevent COVID-19.
COPCOV study was paused after results of treatment trial.
Trump hailed hydroxychloroquine as a game-changer.

Published 30 Jun, 2020 06:33pm

Hydroxychloroquine COVID-19 prevention trials incomplete: WHO

A decades-old malaria and rheumatoid arthritis drug, hydroxychloroquine has been at the centre of political and scientific controversy.

Published 18 Jun, 2020 07:26pm

'No benefit' from hydroxychloroquine for virus: UK trial

Researchers said 1,542 patients were randomly assigned to hydroxychloroquine and compared with 3,132 patients given standard hospital care alone.

Published 05 Jun, 2020 07:48pm

Trump no side effects after two week course of anti-malaria drug

The results of Trump's annual physical found that the 73-year-old president remains healthy but picked up a pound and now weighs 244 pounds.
Trump last month began taking hydroxychloroquine, despite questions about its effectiveness, after two White H

Published 04 Jun, 2020 01:36am

Study that claimed HCQ for treating Covid was 'dangerous' might be fraudulent

nearly 150 doctors signed an open letter to the Lancet calling its article’s conclusions into questions.

Updated 03 Jun, 2020 10:26am

Forex
World
Commodity

Currency	Rate
USD PKR Interbank Selling / May 6	278.40
USD PKR Interbank Buying / May 6	278.20
USD to Japanese Yen / May 6	153.92
USD to Swiss Franc / May 6	0.91
Pound Sterling to USD / May 6	1.25
Euro to USD / May 6	1.08

Stock	Volume
S&P 500 / May 3	5127.79
Tokyo Nikkei / May 3	38236.07
Nasdaq / May 3	16156.33
FTSE 100 / May 3	8213.49
Dow Jones / May 3	38675.68
India Sensex / May 6	74134.73
Hang Seng / May 6	18465.58
Germany DAX 30 / May 6	18032.07

Item	Value
Gold 10 Grams PKR / May 3	205418
Petrol/Litre / May 6	288.49
Crude Oil USD/Barrel / May 6	78.37
Karachi Cotton PKR/37.32 KG / May 6	19935
Gold Spot USD/Ounce / May 6	2311.29
Diesel/Litre / May 6	281.96

Gainers
Losers
Leaders

Stock	Price
786 Invest Ltd / May 6 786 Investments Limited(786)	5 ▼ 0.00 (0.00%)
AL-Abbas Sugar / May 6 Al-Abbas Sugar Mills Limited(AABS)	585 ▼ 0.00 (0.00%)
Agro Allianz / May 6 Agro Allianz Limited(AAL)	16 ▼ 0.00 (0.00%)
AL-Abid Silk / May 6 Al-Abid Silk Mills Limited(AASM)	3.49 ▼ 0.00 (0.00%)
Ali Asghar / May 6 Ali Asghar Textile Mills Limited(AATM)	2.07 ▼ 0.00 (0.00%)
Allied Bank / May 6 Allied Bank Limited(ABL)	87.10 ▼ 0.00 (0.00%)
Abbott Lab. / May 6 Abbott Laboratories (Pakistan) Limited(ABOT)	499.34 ▼ 0.00 (0.00%)
Abson Ind. / May 6 Abson Industries Limited(ABSON)	2.50 ▼ 0.00 (0.00%)
Alfalah ETF. / May 6 Alfalah Consumer Index ETF.(ACIETF)	9.84 ▼ 0.00 (0.00%)

Stock	Price
786 Invest Ltd / May 6 786 Investments Limited(786)	5 ▲ 0.00 (0.00%)
AL-Abbas Sugar / May 6 Al-Abbas Sugar Mills Limited(AABS)	585 ▲ 0.00 (0.00%)
Agro Allianz / May 6 Agro Allianz Limited(AAL)	16 ▲ 0.00 (0.00%)
AL-Abid Silk / May 6 Al-Abid Silk Mills Limited(AASM)	3.49 ▲ 0.00 (0.00%)
Ali Asghar / May 6 Ali Asghar Textile Mills Limited(AATM)	2.07 ▲ 0.00 (0.00%)
Allied Bank / May 6 Allied Bank Limited(ABL)	87.10 ▲ 0.00 (0.00%)
Abbott Lab. / May 6 Abbott Laboratories (Pakistan) Limited(ABOT)	499.34 ▲ 0.00 (0.00%)
Abson Ind. / May 6 Abson Industries Limited(ABSON)	2.50 ▲ 0.00 (0.00%)
Alfalah ETF. / May 6 Alfalah Consumer Index ETF.(ACIETF)	9.84 ▲ 0.00 (0.00%)

Stock	Volume
P.I.A.C.(A) / May 6 Pakistan International Airlines Corp(PIAA)	47,200,500 ▲ 0.00
Cnergyico PK / May 6 Cnergyico PK Limited(CNERGY)	29,719,327 ▲ 0.00
Pak Petroleum / May 6 Pakistan Petroleum Limited(PPL)	21,170,581 ▲ 0.00
Pak Refinery / May 6 Pakistan Refinery Limited(PRL)	16,965,134 ▲ 0.00
The Searle Co. / May 6 The Searle Company Limited(SEARL)	15,793,227 ▲ 0.00
P.T.C.L. / May 6 Pakistan Telecommunication Company Ltd(PTC)	15,054,641 ▲ 0.00
K-Electric Ltd. / May 6 K-Electric Limited(KEL)	14,145,556 ▲ 0.00
WorldCall Telecom / May 6 Worldcall Telecom Limited(WTL)	13,158,668 ▲ 0.00
Telecard Limited / May 6 Telecard Limited(TELE)	12,358,668 ▲ 0.00

Markets →

Calculate your monthly liability in FY24

hydroxychloroquine

Most Popular